Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-04-23 @ 6:53 AM
Study NCT ID:
NCT04320602
Status:
COMPLETED
Last Update Posted:
2024-09-05
First Post:
2020-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALXN1210-PNH-401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None